Delivery Order SPE2DE21D7020-SPE2D625F7ZK4
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- The U.S. Department of Defense's Medical Supply Chain awarded a fixed-price delivery order valued at $17,802.20 to Boston Scientific Corp for agent drug-coated balloons. Issued on September 10, 2025, with an ultimate completion date of September 17, 2025, this delivery order represents a competitive award with no set-aside designation. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes the specialized...
- Boston Scientific Corp has been awarded a delivery order valued at $9,001.72 for agent drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on September 4, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract is funded by the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. Drug-coated balloons are specialized...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F7ZK4Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $21,828.61 for Agent Drug Coated Balloon devices under a fixed price contract with economic price adjustment provisions. The contract was awarded on July 22, 2025, by the Defense Health Agency's Medical Supply Chain and is scheduled for completion by July 29, 2025. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular medical devices to federal healthcare agencies. The award is not set aside for any specific business type, indicating open competition in the federal marketplace. Performance of the contract will be completed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures its comprehensive portfolio of medical technologies. This delivery order is consistent with Boston Scientific's established role as a major federal contractor providing specialized medical devices to the Department of Defense and Department of Veterans Affairs through various indefinite delivery vehicles and purchase orders. The company's federal contract portfolio demonstrates its critical importance to federal healthcare supply chains, with existing agreements spanning cardiovascular interventions, neurostimulation systems, radiation treatment devices, and diagnostic equipment. The Agent Drug Coated Balloon delivery order aligns with Boston Scientific's core competency in interventional cardiology solutions and reflects ongoing federal demand for advanced medical technologies to support military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 7/22/25 |